Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for XOMA Royalty Corporation (XOMA : NSDQ)

• Company Description    XOMA ROYALTY is a biotechnology royalty aggregator. The company acquires the potential future economics associated with pre-commercial therapeutic candidates which have been licensed to pharmaceutical or biotechnology companies. XOMA ROYALTY, formerly known as XOMA Corporation, is based in EMERYVILLE, Calif. Number of Employees: 14

• Price / Volume Information    Yesterday's Closing Price: $41.65 Daily Weekly Monthly 20 Day Moving Average: 397,630 shares Shares Outstanding: 12.54 (millions) Market Capitalization: $522.33 (millions) Beta: 0.90 52 Week High: $42.81 52 Week Low: $22.29 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.92% 4.55% 12 Week 55.64% 43.88% Year To Date 56.64% 44.60%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2200 POWELL STREET SUITE 310 - EMERYVILLE,CA 94608 USA ph: 510-204-7200 fax: 510-649-7571 investorrelations@xoma.com http://www.xoma.com

• General Corporate Information    Officers Owen Hughes - Chief Executive Officer and Director Jack L. Wyszomierski - Chairman Jeffrey Trigilio - Chief Financial Officer Heather L. Franklin - Director Natasha Hernday - Director Peer Information XOMA Royalty Corporation (CORR.) XOMA Royalty Corporation (RSPI) XOMA Royalty Corporation (CGXP) XOMA Royalty Corporation (BGEN) XOMA Royalty Corporation (GTBP) XOMA Royalty Corporation (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 98419J206 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/12/26 Share - Related Items Shares Outstanding: 12.54 Most Recent Split Date: 10.00 (0.05:1) Beta: 0.90 Market Capitalization: $522.33 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.21 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.94 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/26

• Fundamental Ratios P/E Current FY Estimate: 44.31 Trailing 12 Months: 99.17 PEG Ratio: - Price Ratios Price/Book: 5.63 Price/Cash Flow: 73.05 Price / Sales: 10.76 EPS Growth vs. Year Ago Period: 183.33% vs. Previous Quarter: 41.67% Sales Growth vs. Year Ago Period: -22.59% vs. Previous Quarter: -10.46% ROE 03/31/26 - 12.56 12/31/25 - 10.32 09/30/25 - 3.10 ROA 03/31/26 - 4.11 12/31/25 - 3.49 09/30/25 - 1.03 Current Ratio 03/31/26 - 3.59 12/31/25 - 3.37 09/30/25 - 3.91 Quick Ratio 03/31/26 - 3.59 12/31/25 - 3.37 09/30/25 - 3.91 Operating Margin 03/31/26 - 21.80 12/31/25 - 16.27 09/30/25 - 5.04 Net Margin 03/31/26 - 53.46 12/31/25 - 45.75 09/30/25 - 32.28 Pre-Tax Margin 03/31/26 - 69.85 12/31/25 - 61.01 09/30/25 - 34.04 Book Value 03/31/26 - 7.40 12/31/25 - 6.77 09/30/25 - 7.27 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.96 12/31/25 - 1.15 09/30/25 - 1.07 Debt-to-Capital 03/31/26 - 44.03 12/31/25 - 48.13 09/30/25 - 46.65

Powered by Zacks Investment Research ©